189 related articles for article (PubMed ID: 30115013)
1. Adult minimal-change disease: observational data from a UK centre on patient characteristics, therapies, and outcomes.
Fenton A; Smith SW; Hewins P
BMC Nephrol; 2018 Aug; 19(1):207. PubMed ID: 30115013
[TBL] [Abstract][Full Text] [Related]
2. The Clinical Course of Minimal Change Nephrotic Syndrome With Onset in Adulthood or Late Adolescence: A Case Series.
Maas RJ; Deegens JK; Beukhof JR; Reichert LJ; Ten Dam MA; Beutler JJ; van den Wall Bake AWL; Rensma PL; Konings CJ; Geerse DA; Feith GW; Van Kuijk WH; Wetzels JF
Am J Kidney Dis; 2017 May; 69(5):637-646. PubMed ID: 28089478
[TBL] [Abstract][Full Text] [Related]
3. Tacrolimus therapy in adults with steroid- and cyclophosphamide-resistant nephrotic syndrome and normal or mildly reduced GFR.
Li X; Li H; Ye H; Li Q; He X; Zhang X; Chen Y; Han F; He Q; Wang H; Chen J
Am J Kidney Dis; 2009 Jul; 54(1):51-8. PubMed ID: 19406543
[TBL] [Abstract][Full Text] [Related]
4. Clinico-biochemical Profile of Biopsy-proven Minimal Change Disease in Adults from a Tertiary Care Center in South India.
Udupa KRN; Eshwarappa M; Gurudev KC; Gireesh MS; Reddy R; Yousuff M
Saudi J Kidney Dis Transpl; 2023 May; 34(3):242-249. PubMed ID: 38231719
[TBL] [Abstract][Full Text] [Related]
5. Influence of acute kidney injury on the time to complete remission in adult minimal change nephrotic syndrome: a single-centre study.
Komukai D; Hasegawa T; Kaneshima N; Takayasu M; Sato Y; Hirose M; Yoshimura A
Nephrology (Carlton); 2016 Oct; 21(10):887-92. PubMed ID: 26603689
[TBL] [Abstract][Full Text] [Related]
6. Adult minimal-change disease: clinical characteristics, treatment, and outcomes.
Waldman M; Crew RJ; Valeri A; Busch J; Stokes B; Markowitz G; D'Agati V; Appel G
Clin J Am Soc Nephrol; 2007 May; 2(3):445-53. PubMed ID: 17699450
[TBL] [Abstract][Full Text] [Related]
7. [Clinical characteristics of adult-onset minimal change nephrotic syndrome in our hospital].
Mori D; Shinzawa M; Namba T; Yamaguchi Y; Itano S; Imakita N; Matsuda J; Murata H; Takeji M; Yamamoto R; Isaka Y; Yamauchi A
Nihon Jinzo Gakkai Shi; 2012; 54(7):1023-30. PubMed ID: 23234214
[TBL] [Abstract][Full Text] [Related]
8. Age of Onset and Disease Course in Biopsy-Proven Minimal Change Disease: An Analysis From the Cure Glomerulonephropathy Network.
Chen DP; Helmuth ME; Smith AR; Canetta PA; Ayoub I; Mucha K; Kallash M; Kopp JB; Gbadegesin R; Gillespie BW; Greenbaum LA; Parekh RS; Hunley TE; Sperati CJ; Selewski DT; Kidd J; Chishti A; Reidy K; Mottl AK; Gipson DS; Srivastava T; Twombley KE;
Am J Kidney Dis; 2023 Jun; 81(6):695-706.e1. PubMed ID: 36608921
[TBL] [Abstract][Full Text] [Related]
9. Indications for kidney biopsy in idiopathic childhood nephrotic syndrome.
Alshami A; Roshan A; Catapang M; Jöbsis JJ; Kwok T; Polderman N; Sibley J; Sibley M; Mammen C; Matsell DG;
Pediatr Nephrol; 2017 Oct; 32(10):1897-1905. PubMed ID: 28540445
[TBL] [Abstract][Full Text] [Related]
10. [Renal function in subjects with minimal change steroid-responsive nephrotic syndrome in childhood].
Strzelecka-Lichota A
Ann Acad Med Stetin; 2004; 50(2):41-9. PubMed ID: 16529164
[TBL] [Abstract][Full Text] [Related]
11. Adult-onset minimal change disease: the significance of histological chronic changes for clinical presentation and outcome.
Stefan G; Busuioc R; Stancu S; Hoinoiu M; Zugravu A; Petre N; Mircescu G
Clin Exp Nephrol; 2021 Mar; 25(3):240-250. PubMed ID: 33090339
[TBL] [Abstract][Full Text] [Related]
12. Glomerular tip lesion: a distinct entity within the minimal change disease/focal segmental glomerulosclerosis spectrum.
Stokes MB; Markowitz GS; Lin J; Valeri AM; D'Agati VD
Kidney Int; 2004 May; 65(5):1690-702. PubMed ID: 15086908
[TBL] [Abstract][Full Text] [Related]
13. Comparison between patients with IgA nephropathy with minimal change disease and patients with minimal change disease.
Li XW; Cheng SQ; Liang SS; Le WB; Zeng CH; Wang JQ; Liu ZH
Clin Nephrol; 2016 May; 85(5):273-81. PubMed ID: 26951969
[TBL] [Abstract][Full Text] [Related]
14. Effective treatment with rituximab for the maintenance of remission in frequently relapsing minimal change disease.
Papakrivopoulou E; Shendi AM; Salama AD; Khosravi M; Connolly JO; Trompeter R
Nephrology (Carlton); 2016 Oct; 21(10):893-900. PubMed ID: 26860320
[TBL] [Abstract][Full Text] [Related]
15. Spectrum of steroid-resistant and congenital nephrotic syndrome in children: the PodoNet registry cohort.
Trautmann A; Bodria M; Ozaltin F; Gheisari A; Melk A; Azocar M; Anarat A; Caliskan S; Emma F; Gellermann J; Oh J; Baskin E; Ksiazek J; Remuzzi G; Erdogan O; Akman S; Dusek J; Davitaia T; Özkaya O; Papachristou F; Firszt-Adamczyk A; Urasinski T; Testa S; Krmar RT; Hyla-Klekot L; Pasini A; Özcakar ZB; Sallay P; Cakar N; Galanti M; Terzic J; Aoun B; Caldas Afonso A; Szymanik-Grzelak H; Lipska BS; Schnaidt S; Schaefer F;
Clin J Am Soc Nephrol; 2015 Apr; 10(4):592-600. PubMed ID: 25635037
[TBL] [Abstract][Full Text] [Related]
16. Tacrolimus improves proteinuria remission in adults with cyclosporine A-resistant or -dependent minimal change disease.
Xu D; Gao X; Bian R; Mei C; Xu C
Nephrology (Carlton); 2017 Mar; 22(3):251-256. PubMed ID: 28035723
[TBL] [Abstract][Full Text] [Related]
17. Idiopathic minimal change nephrotic syndrome in older adults: steroid responsiveness and pattern of relapses.
Tse KC; Lam MF; Yip PS; Li FK; Choy BY; Lai KN; Chan TM
Nephrol Dial Transplant; 2003 Jul; 18(7):1316-20. PubMed ID: 12808168
[TBL] [Abstract][Full Text] [Related]
18. Predictors of Relapse in Adult-Onset Nephrotic Minimal Change Disease.
Lee H; Yoo KD; Oh YK; Kim DK; Oh KH; Joo KW; Kim YS; Ahn C; Han JS; Lim CS
Medicine (Baltimore); 2016 Mar; 95(12):e3179. PubMed ID: 27015208
[TBL] [Abstract][Full Text] [Related]
19. Association of initial prednisolone dose with remission, relapse, and infectious complications in adult-onset minimal change disease.
Tanabe K; Samejima KI; Fukata F; Kosugi T; Tsushima H; Morimoto K; Okamoto K; Matsui M; Eriguchi M; Maruyama N; Akai Y; Tsuruya K
Clin Exp Nephrol; 2022 Jan; 26(1):29-35. PubMed ID: 34365595
[TBL] [Abstract][Full Text] [Related]
20. Short-Term Steroid Regimen for Adult Steroid-Sensitive Minimal Change Disease.
Ozeki T; Katsuno T; Hayashi H; Kato S; Yasuda Y; Ando M; Tsuboi N; Hagiwara D; Arima H; Maruyama S
Am J Nephrol; 2019; 49(1):54-63. PubMed ID: 30557879
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
